Prediction of α-synuclein seed amplification assay positivity in remotely followed LRRK2 G2019S carriers using a validated data-driven model
{{output}}
The α-synuclein seed amplification assay (SAA) is a biomarker for Parkinson's disease (PD) but requires cerebrospinal fluid. We applied a validated model to predict α-synuclein SAA+ using remotely collected data in LRRK2 G2019S carriers. VALOR-PD participan... ...
